在微质中的阿波利波蛋白E聚合,在阿尔茨海默病中的种子β-氨基粉症
Miguel A Jiménez-Acosta1, Cristina A Luckie-Duque1, Marco A Meraz-Ríos1
1Departamento de Biomedicina Molecular, CINVESTAV-IPN, Av. IPN 2508, San Pedro Zacatenco, 07360 Mexico City, Mexico.
Journal of leukocyte biology
|January 23, 2025
概括
有害的蛋白质聚合物驱动阿尔茨海默病 (AD). 研究人员发现,微质中的Apolipoprotein E (APOE) 聚合物可以启动β-粉样蛋白 (Aβ) 斑块的形成,为AD的病原性提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 病理生理学涉及种子蛋白质聚合物的扩散.
- 阿尔茨海默病的病理级联的确切开始尚未完全理解.
- 脂蛋白E (APOE) 聚合与阿尔茨海默病有关,但其在启动粉蛋白β (Aβ) 病理中的作用需要澄清.
相关概念视频
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439


